Skip to Main Content

HelixTalk

This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.

How Do I Listen?

HelixTalk is available via Apple Podcasts (or by searching for HelixTalk), by subscribing to our RSS feed, subscribing to our mailing list, or by listening to any episode in your browser (below).

Subscribe to Our Mailing List

Sean P. Kane, PharmD, BCPS and Khyati S. Patel, PharmD, BCACP sit at a table with a laptop, engaged in a discussion about their podcast HelixTalk.

HelixTalk Episodes

HelixTalk #197 - Sweet Deal of Updates in Diabetes Pharmacotherapy from the ADA 2026 Standards of Care

Date posted: April 3, 2026, 3:05 pm

In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, particularly focusing on changes in pharmacotherapy recommendations and the supporting evidence.


HelixTalk #196 - Stretching the Stroke Clock to 2026: A Brief Review of the 2026 Acute Ischemic Stroke Guidelines

Date posted: March 18, 2026, 1:53 pm

In this episode, we review key updates from the 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke, including changes to IV thrombolysis, antiplatelet therapy, endovascular treatment, blood pressure goals, and glycemic goals.


HelixTalk #195 - Burning Questions about Uncomplicated UTI Diagnosis and Treatment

Date posted: January 22, 2026, 12:30 pm

In this episode, we review the clinical presentation, diagnosis, and treatment of uncomplicated urinary tract infections.


HelixTalk #194 - 5-HT3 Receptor Antagonists for Nausea/Vomiting: An In-Depth Drug Class Review

Date posted: December 5, 2025, 7:05 am

In this episode, we review the pharmacology, indications, adverse effects, and unique drug characteristics of 5-HT3 receptor antagonists such as ondansetron (Zofran) and palonosetron (Aloxi).